View in EDS

Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study.

Saved in:
Bibliographic Details
Title: Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study.
Authors: Shah AP; The University of Chicago, Chicago, IL, United States of America. Electronic address: ashah@bsd.uchicago.edu., Freeman JV; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States of America., Alkhouli M; Mayo Clinic, Rochester, MN, United States of America., Agarwal H; CHI Creighton University School of Medicine - Bergan Mercy Hospital, Omaha, NE, United States of America., Coylewright M; Heart and Vascular Center, Essentia Health, Duluth, MN, United States of America., Makkar A; Arizona Heart Arrhythmia Associates, Phoenix, AZ, United States of America., Anderson J; Abbott Structural Heart, Plymouth, MN, United States of America., Gage R; Abbott Structural Heart, Plymouth, MN, United States of America., Freixa X; Hospital Clinic of Barcelona, Barcelona, Spain., Nielsen-Kudsk JE; Aarhus University Hospital, Aarhus N, Denmark., Lakkireddy D; Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS, United States of America.
Source: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2026 May; Vol. 86, pp. 1-9. Date of Electronic Publication: 2025 Jul 25.
Publication Type: Journal Article; Comparative Study; Multicenter Study; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0938 (Electronic) Linking ISSN: 18780938 NLM ISO Abbreviation: Cardiovasc Revasc Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-0938
DOI:10.1016/j.carrev.2025.07.012